Last reviewed · How we verify
pTTL
At a glance
| Generic name | pTTL |
|---|---|
| Also known as | personal tumour-trained lymphocytes |
| Sponsor | Neogap Therapeutics AB |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A First-In-Human Trial of pTTL in Advanced Colorectal Cancer (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- pTTL CI brief — competitive landscape report
- pTTL updates RSS · CI watch RSS
- Neogap Therapeutics AB portfolio CI